TrialThe Journal of clinical endocrinology and metabolism2019

Acipimox Acutely Increases GLP-1 Concentrations in Overweight Subjects and Hypopituitary Patients.

Esben Thyssen Vestergaard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.